Gerald said there is a lot to come in the upcoming few weeks.

1. Submissions for RPDD for pediatric burns and hairy nevus.

2. Release o f early eltoprazine data in Alzheimer's aggression.

3. Release of new ESS study from Dr. Boyce.

4. GMP certification of ESS by Lonza.

5. Spin-off of diagnostics division.

6. Start ESS trials and engage DoD regarding more funding.

I think we are also awaiting CTE results for Lympro (although he didn't mention this).